LANXESS worldwide

Corporate Website en | de

Asia

  • Australia en

  • China cn | en

  • India en

  • Indonesia en

  • Japan jp

  • Korea kr

  • Malaysia en

  • Pakistan en

  • Philippines en

  • Singapore

  • Thailand en

  • Vietnam en

EMEA

  • Austria en

  • Belgium nl

  • Czech en

  • France fr

  • Hungary en

  • Italy en

  • Netherlands en

  • Poland en

  • Russia en

  • Serbia en

  • Slovakia en

  • Spain en

  • Turkey en

  • United Arab Emirates en

  • United Kingdom en

Americas

Contact

LANXESS Canada Contacts

Contact our Sites in Canada

 

Media Inquiries

Global Press Releases

2020-09-18

African Swine Fever: Virkon S disinfectant with proven efficacy in just 15 seconds

  • Study proves rapid effectiveness of LANXESS’ Virkon S disinfectant against African Swine Fever
  • Virkon S kills the ASF virus in just 15 seconds
  • With Virkon S and Virkon LSP, LANXESS offers two high-performance disinfectants for farmers

Cologne, September 18, 2020 – African Swine Fever (ASF) has reached Germany. Six confirmed cases of ASF have been detected in dead wild boar carcasses in Brandenburg since Thursday, 10th September. To date, there is no effective vacine against the disease thus making it extremely important to ensure biosecurity protocols are in place to help protect against the virus from entering German farmed swine populations.

“Biosecurity disease prevention measures and utilizing proven effective and powerful veterinary disinfectants still provides the best form of protection against the ASF virus.” says Anneliese Bischof, Head of Market Segment Disinfection at LANXESS. “Barrier control and external biosecurity measures are critical to help ensure wild boars and other wild animals cannot enter. In addition, all surfaces, equipment, footwear and vehicles must be cleaned and disinfected on a continuous basis to help prevent the introduction and spread of the disease.

“Virkon S & Virkon LSP are powerful broad spectrum disinfectants and among the leading products in the field of biosecurity and independently. They are proven to rapidly kill the ASF virus. The efficacy testing against the virus was undertaken by a renowned Spanish institute for agriculture, food research and technology. Virkon LSP achieved complete inactivation of the ASF virus at a 1:400 dilution rate with a 60 second contact time, with Virkon S killing the pathogen in just 15 seconds at a 1:100 dilution rate.

Virkon – the science to kill pathogens

LANXESS has more than 30 years of scientific formulationdevelopment expertise. With Virkon S and Virkon LSP, the companyoffers two products with different active ingredients in the fightagainst the spread of the virus. Virkon S is a powder disinfectant andcontains the active ingredient potassium monopersulfate. Virkon LSPis a liquid disinfectant based on the synthetic phenolic activeingredients CMK and OPP.

LANXESS’ Virkon range of disinfectants are dissolved in water andcan be used extensively in the hygiene concepts of farms, fromdisinfection thresholds in the driveway to disinfection of stables.

Further information: virkon.com.

LANXESS is a leading specialty chemicals company with sales of EUR 6.8 billion in 2019. The company currently has about 14,400 employees in 33 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.

Information for editors:
All LANXESS news releases and their accompanying photos can be found at press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at photos.lanxess.com. 

You can find further information concerning LANXESS chemistry in our WebMagazine at http://webmagazine.lanxess.com.

Follow us on Twitter, Facebook, Linkedin and YouTube:

http://www.twitter.com/LANXESS
http://www.facebook.com/LANXESS
http://www.linkedin.com/company/lanxess
http://www.youtube.com/lanxess


Contact

Mark Mätschke

Mark Mätschke
Head of General Press and Trade & Technical Press

Phone: +49 221 8885 3372

Fax: +49 221 8885 4994

send E-Mail

Download